Ayush Ministry warns against misleading ads for Ayurveda, Siddha, Unani, and Homeopathy drugs

Public urged to avoid self-medication and report misleading advertisements; Ministry clarifies licensing processes under Drugs and Cosmetics Act.

By  Storyboard18Oct 9, 2024 12:14 PM
Ayush Ministry warns against misleading ads for Ayurveda, Siddha, Unani, and Homeopathy drugs
In a firm advisory to the public, the ministry encouraged people to consult Ayush practitioners before using any ASU&H medications. (Image source: Healthline)

The Union Ayush Ministry issued a public notice on Tuesday, warning that advertising Ayurveda, Siddha, Unani, and Homeopathy (ASU&H) drugs with "miraculous or supernatural" claims for treating diseases is illegal and can pose serious risks to public health, as per media reports.

The ministry stressed that such advertisements promote unverified or false claims, misleading the public and potentially endangering their well-being.

Clarifying its role, the ministry stated that it neither certifies nor approves and ASU&H companies or their medicines. The license to manufacture and sell such drugs is issued by the State and Union Territory Licensing Authorities, as outlined by the Drugs and Cosmetics Act, 1940.

"It is illegal to advertise ASU&H drugs claiming miraculous or supernatural effects for the treatment of diseases. Such advertisements can mislead and endanger public health by promoting unverified or false claims," the ministry said, as per reports.

Furthermore, under the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954, advertisements for drugs and magic remedies targeting specific diseases and conditions are strictly prohibited. Violators of this Act are subject to penalties as prescribed by law.

The ministry also highlighted that ASU drugs containing Schedule El substances must be consumed only under the supervision of a registered medical practitioner from the respective Ayush discipline. The labels of these medicines must carry the cautionary note, "Caution to be taken under medical supervision," in both Hindi and English.

In a firm advisory to the public, the ministry encouraged people to consult Ayush practitioners before using any ASU&H medications.

It further warned against the dangers of self-diagnosis and self-medication with such drugs, urging citizen to report misleading advertisements, false claims, or fake medicines to the State Licensing Authorities or the Ministry of Ayush for appropriate action.


Tags
First Published on Oct 9, 2024 12:14 PM

More from Storyboard18

Advertising

Life Insurers launch Rs 450 crore pan-India awareness campaign

Life Insurers launch Rs 450 crore pan-India awareness campaign

Advertising

When Ramesh-Suresh became synonymous with Cadbury 5 Star

When Ramesh-Suresh became synonymous with Cadbury 5 Star

How it Works

YouTube rolls out shopping stickers for Shorts

YouTube rolls out shopping stickers for Shorts

Brand Marketing

Mahindra Holidays & Resorts cuts adex by 26.4% to Rs 156.7 crore in FY25

Mahindra Holidays & Resorts cuts adex by 26.4% to Rs 156.7 crore in FY25

Advertising

X to charge advertisers based on ad size, says Elon Musk

X to charge advertisers based on ad size, says Elon Musk

Brand Marketing

Campaign turnaround down 70%, production costs cut by 85%: How Indian brands are letting AI take over creative wheel

Campaign turnaround down 70%, production costs cut by 85%: How Indian brands are letting AI take over creative wheel

Brand Marketing

'40% of spends are on digital media; Over 12,000 influencers collaborate with our brands': HUL's Nitin Paranjpe

'40% of spends are on digital media; Over 12,000 influencers collaborate with our brands': HUL's Nitin Paranjpe

Advertising

FMCG major ITC cuts ad spend to Rs 1,331 crore in FY25

FMCG major ITC cuts ad spend to Rs 1,331 crore in FY25